Increased plasma dopamine in patients presenting with the pseudopheochromocytoma quandary: Retrospective analysis of 10 years' experience

Journal of Hypertension

Volumn 16, Issue 10, 1998, Pages 1531-1537

  Kuchel, Otto ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Catecholamines; Dopamine sulfate; Idiopathic hypovolemia; Mastocytosis; Pseudopheochromocytoma

Indexed keywords

ADRENALIN; COCAINE; DOPAMINE; NORADRENALIN;

ADRENAL TUMOR; ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DOPAMINE BLOOD LEVEL; DRUG ABUSE; FEMALE; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; HYPERVENTILATION; HYPOTENSION; HYPOVOLEMIA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MASTOCYTOSIS; NORADRENALIN BLOOD LEVEL; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PSEUDOTUMOR; RETROSPECTIVE STUDY; SWEATING;

EID: 0031689157     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816100-00019     Document Type: Article

References (37)

1. Page IH. A syndrome simulating diencephalic stimulation occurring in patients with essential hypertension. Am J Med Sci 1935; 190:9-14.
2. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 1989; 2 (suppl):140S-146S.
3. Wallin BG. Clinical neurophysiology. In: Stalberg E, Young RR (editors). Butterworths International Medical Review, Neurology 1. London: Butterworths; 1981. pp. 145-167.
4. Kuchel O, Buu NT, Larochelle P, Hamet P, Genest J Jr. Episodic dopamine discharge in paroxysmal hypertension. Arch Intern Med 1986; 146:1315-1320.
5. Goldstein DS, Mezey E, Yamamoto T, Aneman A, Friberg P, Eisenhofer G. Is there a third peripheral catecholaminergic system? Endogenous dopamine as an autocrine/paracrine substance derived from plasma DOPA and inactivated by conjugation. Hypertens Res 1995; 18 (suppl I): S93-S99.
6. Yoshizumi M, Kitagawa T, Hori T, Katoh I, Houchi H, Ohuchi T, et al. Physiological significance of plasma sulfoconjugated dopamine in patients with hypertension: clinical and experimental studies. Life Sci 1996; 59:323-330.
7. Sisson JC, Trager MS, Valk TW, Gross MD, Swanson DP, Willand DM, et al. Scintigraphic localisation of pheochromocytoma. N Engl J Med 1981; 305:12-17.
8. Lawrence AM. Glucagon and pheochromocytoma. Ann Intern Med 1970; 73:852-853.
9. Bravo BL, Tarazi RC, Fouad FM, Vidt OJ, Gifford RW Jr. Clonidine suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med 1981; 305:623-626.
10. Wang PC, Buu NT, Kuchel O, Genest J. Conjugation patterns of endogenous plasma catecholamines in human and rat: a new specific method for analysis of glucuronide conjugated catecholamines. J Lab Clin Med 1983; 101:141-151.
11. Cohn JN. Paroxysmal hypertension and hypovolemia. N Engl J Med 1966; 275:643-646.
12. 51 modifications from original technique. J Lab Clin Med 1956; 47:255-260.
13. Fouad FM, Tadena-Thome L, Bravo EL, Tarazi RC. Idiopathic hypovolemia. Ann Intern Med 1986; 104:298-303.
14. Roberts LJ. Mastocytosis. In: Robertson I, Low PA, Polinsky RI (editors). Primer on the autonomic nervous system. San Diego: Academic Press Inc.; 1996. pp. 313-315.
15. Robertson D, Hollister AS, Biaggioni I, Netterville JL, Mosqueda-Garcia R, Robertson RM. The diagnosis and treatment of baroreflex failure. N Engl J Med 1993; 329:1449-1455.
16. Morimoto S, Sasaki S, Miki S, Kawa T, Itoh H, Narata T, et al. Pulsatile compression of the rostral ventrolateral medulla in hypertension. Hypertension 1997; 29:514-518.
17. Mathias CJ. Autonomic disturbances in spinal cord injuries. In: Robertson D, Low PA, Polinsky RJ (editors). Primer on the autonomic nervous system. San Diego: Academic Press; 1996. pp. 230-236.
18. Kuchel O. Pseudopheochromocytoma. Clinical conference. Hypertension 1985; 7:151-158.
19. Manger WM, Gifford RW. Clinical and experimental pheochromocytoma. Second edition. Cambridge, Massachusetts: Blackwell Science Inc. 1996. pp. 92-116.
20. Kopin IJ. Catecholamines, adrenal hormones and stress. In: Krieger DT, Hughes JC (editors). Neuroendocrinology. Sunderland: Sinauer; 1980. pp. 159-166.
21. Mann SP. Assay of tyrosine hydroxylase in tissue homogenates: effects of Triton-X, sodium, calcium and cyclic AMP. Biochem Pharmacol 1980; 29:1593-1595.
22. 1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro. Br J Clin Pharmacol 1986; 22:535-540.
23. Kuchel O, Léveillé J. Idiopathic hypovolemia: a self-perpetuating autonomic dysfunction? Clin Auton Res 1996; 6:277-278.
24. Sharman DF, Kelly MJ, Loncar-Stefanovic HL. The metabolism of dopamine in the blood of ruminant animals: an enzyme system to metabolize dopamine in these species? Comp Bioch Physiol 1983; 75:217-222.
25. Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990; 323:1401-1405.
26. Racz K, Buu NT, Kuchel O. Regional distribution of free and sulfo-conjugated catecholamines in the bovine adrenal cortex and medulla. Can J Physiol Pharmacol 1984; 62:622-626.
27. Nielsen EB, Jorgensen F, Conway J, Sleight P. Severe paroxysmal hypertension induced by a subconscious Valsalva-like maneuvers. Clin Auton Res 1992; 2:281-284.
28. Faraj BA, Camp VM, Davis DC, Kutner M, Cotsonis GA, Holloway T. Elevated concentrations of dopamine sulfate in plasma of cocaine abusers. Biochem Pharmacol 1993; 46:1453-1457.
29. Kudva YC, Young WF Jr. Lightheaded spells and hypertension. Lancet 1997; 350:1140.
30. Kuchel O, Buu NT, Harnet P, Nowaczynski W, Genest J. Free and conjugated dopamine in pheochromocytoma, primary aldosteronism and essential hypertension. Hypertension 1979; 1:267-273.
31. Kuchel O, Nguyen TB, Fontaine A, Hamet P, Beroniade V, Larochelle P, et al. Free and conjugated plasma catecholamines in hypertensive patients with and without pheochromocytoma. Hypertension 1980; 2:177-186.
32. Horwitz DA, Sjoerdsma A. Some interrelationships between elevation of blood pressure and angina pectoris. Circ Res 1964; 13:39-48.
33. Weissmann NJ, Shear MK, Kramer FR, Devereux RB. Contrasting patterns of autonomic dysfunction in patients with mitral valve prolapse and panic attacks. Am J Med 1987; 82:880-888.
34. Kaplan NM. Anxiety-induced hyperventilation. A common cause of symptoms in patients with hypertension. Arch Intern Med 1997; 157:945-948.
35. Todd GPA, Chadwick IG, Yeo WW, Jackson PR, Ramsay LE. Pressor effect of hyperventilation in healthy subjects. J Hum Hypertens 1995; 9:119-122.
36. Pequignot JM, Favier R, Desplanches D, Peyrin L, Flandrois R. Free dopamine in dog plasma: lack of relationship with sympathoadrenal activity. J Appl Physiol 1985; 58:763-769.
37. Davies SJC, Ghahramani P, Jackson PR, Hippisleycox J, Yeo WW, Ramsay LE. Panic disorder, anxiety and depression in resistant hypertension: a case-control study. J Hypertens 1997; 15:1077-1082.